Showing 1 posts of 1 posts found.
Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement